Hypersecretion of central corticotropin-releasing hormone (CRH) has been implicated in the pathophysiology of affective disorders. Both, basic and clinical studies suggested that disrupting CRH signaling through CRH type 1 receptors (CRH-R1) can ameliorate stressrelated clinical conditions. To study the effects of CRH-R1 blockade upon CRH-elicited behavioral and neurochemical changes we created different mouse lines overexpressing CRH in distinct spatially restricted patterns. CRH overexpression in the entire central nervous system, but not when overexpressed in specific forebrain regions, resulted in stress-induced hypersecretion of stress hormones and increased active stress-coping behavior reflected by reduced immobility in the forced swim test and tail suspension test. These changes were related to acute effects of overexpressed CRH as they were normalized by CRH-R1 antagonist treatment and recapitulated the effect of stress-induced activation of the endogenous CRH system. Moreover, we identified enhanced noradrenergic activity as potential molecular mechanism underlying increased active stress-coping behavior observed in these animals. Thus, these transgenic mouse lines may serve as animal models for stress-elicited pathologies and treatments that target the central CRH system.
Introduction
Corticotropin-releasing hormone (CRH)-also designated as corticotropin-releasing factor (CRF)-is important in coordinating the neuroendocrine, autonomic, behavioral and immunological responses to various stressful stimuli. 1 Besides its function as the major physiological regulator of the hypothalamic-pituitary-adrenocortical (HPA) system, CRH is capable of modulating a wide range of behaviors, including anxiety-related behavior, arousal, sensory information processing, learning and memory as well as locomotor activity. [2] [3] [4] Most behavioral effects of CRH are attributed to extrahypothalamic neuronal circuits including neocortical, limbic and brainstem structures where CRH functions as a neuromodulator. Dysregulation of the CRH system and accompanying chronically elevated levels of CRH are implicated in human stress-related and affective disorders, including anxiety disorders and major depression. [5] [6] [7] In this line, elevated levels of CRH in the cerebrospinal fluid, 5 increased numbers of CRH and CRH/arginine vasopressin-expressing neurons and elevated CRH mRNA levels in the paraventricular nucleus of the hypothalamus (PVN), 8 as well as decreased CRH binding sites in the frontal cortex have been demonstrated in depressed patients. In addition, animal studies involving central application of CRH revealed phenotypic alterations reminiscent of symptoms observed in affected subjects. 4 Moreover, CRH receptor antagonists are capable of attenuating the behavioral consequences of stress, underscoring the role of endogenous CRH in mediating many stress-induced behaviors. Finally, clinical trials have demonstrated the efficacy of a selective CRH type 1 receptor (CRH-R1) antagonist in treating depressed patients. 9 Unlike classical antidepressants that modulate the monoaminergic system, CRH receptor antagonists have not produced comparable results in antidepressant screening paradigms in rodents, such as the forced swim test (FST) or the tail suspension test. 10 In these tests animals were studied under basal conditions. However, according to the hypothesis by Hö kfelt and Lundberg, 11 neuropeptides, unlike monoamines, are only secreted at substantial amounts under pathological conditions or severe stress. Accordingly, anxiolytic-like activities of CRH-R1 antagonists such as DMP696 and R121919 are best observed in animals that have increased levels of CRH, and are hyperresponsive or more susceptible to stress. 12 These findings are in agreement with a blunted stress hormone response in healthy humans pretreated with a CRH-R1 antagonist. 13 To study the effects of central CRH hyperactivity in an animal model, CRH transgenic mouse lines were established expressing CRH either under the control of the broadly active metallothionein (CRH-Tg) or the central nervous system (CNS)-restricted Thy-1.2 (CRH-OE 2122 ) promoter. 14, 15 In both cases, unrestricted CRH overexpression resulted in elevated adrenocorticotropin (ACTH) and corticosterone levels accompanied by symptoms of Cushing-like syndrome, complicating the interpretation of stress-related behavioral results. To circumvent these problems we developed a mouse model that permits the overexpression of CRH without producing marked neuroendocrine disturbances under basal conditions. Combining the knock-in of a single copy of the murine Crh cDNA into the ROSA26 (R26) locus 16 with the Cre/loxP system has enabled us to overexpress CRH in a spatio-temporally regulated fashion at different dosages. We activated CRH expression in the entire brain and in specific types of neurons within the forebrain using Nes-cre, 17 Camk2a-cre 18 and Dlx-cre. 19 We demonstrated that this approach is an effective way to study the behavioral and neuroendocrine effects of spatially confined CRH overexpression in mice.
Materials and methods

Targeting vector
The targeting vector was based on pROSA26-1 bearing 5.5-kb homology to the murine ROSA26 locus (R26) and a diphtheria toxin (DTA) expression cassette. 20 It was constructed by introducing the following components into the unique XbaI site of pROSA26-1: adenovirus splice acceptor (SA), loxP, PGK-Neo-including PGK polyadenylation sequence (pA) and two copies of the SV40 pA (PGK-Neo-3 Â pA), loxP, IRES-LacZ and bovine growth hormone (bGH) pA (from 5 0 to 3 0 ). The SA and bGH pA were subcloned from pSAbgeo. 21 The IRES-LacZ was isolated and modified from ETLpA-/LTNL. 22 The loxP-flanked PGK-Neo-3 Â pA cassette was amplified by PCR from genomic tail DNA of R26 reporter mice. 20 The DTA cassette was inverted and concomitantly an SwaI site was introduced for linearization. The murine Crh cDNA was inserted in a unique PacI site between the second loxP site and the IRES-LacZ cassette. External probes used for identification of homologous recombination events were amplified by PCR from genomic DNA and cloned using the TOPO TA cloning kit (Invitrogen, Karlsruhe, Germany). 5 0 -Probe: forward 5 0 -GCG-AGA-CTC-GAG-TTA-GGC-3 0 and reverse 5 0 -GCG-GCC-GCC-GCC-CGC-CTG-CG-3 0 (150 bp); 3 0 -probe: forward 5 0 -GTT-GAG-CCA-CTG-AGA-ATG-G-3 0 and reverse 5 0 -GAA-ACT-ACA-ACC-ATT-GTT-CAT-3 0 (662 bp).
Generation of conditional CRH overexpressing mice
The linearized targeting vector was electroporated into TBV2 embryonic stem (ES) cells (129S2). Mutant ES cell clones were identified by Southern blot analysis of genomic ES cell DNA digested with EcoRV or ApaI using the external 5 0 -or 3 0 -probe respectively. Mutant ES cells were used to generate chimeric mice by blastocyst injection. Germ-line transmission of the modified R26 allele (R26 flopCrh floxed stop) was confirmed in offspring from male chimeras bred to wild-type C57BL/6J mice. For the conditional, CNSrestricted overexpression of CRH (CRH-COE-Nes), obtained R26
þ /flopCrh mice were crossed to transgenic nestin (Nes)-cre mice. 17 Resulting heterozygous R26 þ /flopCrh and R26 þ /flopCrh Nes-cre F 1 animals were intercrossed to obtain in the F 2 generation animals of the desired genotypes: R26
Nes-cre (CRH-COE het -Nes) and R26 flopCrh/flopCrh Nes-cre (CRH-COE hom -Nes). For the forebrain-restricted overexpression of CRH in principal neurons (CRH-COECam), R26 þ /flopCrh mice were crossed to transgenic Camk2a-cre mice. 18 As above,
Camk2a-cre (CRH-COE het -Cam) and R26 flopCrh/flopCrh Camk2a-cre (CRH-COE hom -Cam) animals were obtained in the F 2 generation. CRH-COE-Dlx mice overexpressing CRH in GABAergic neurons of the forebrain were accordingly generated using Dlx5/6 (Dlx)-cre mice. 19 Genotyping was performed by PCR using primers: ROSA-1, 5
0 -AAA-GTC-GCT-CTG-AGT-TGT-T AT-3 0 ; ROSA-2, 5 0 -GCG-AAG-AGT-TTG-TCC-TCA-ACC-3 0 and ROSA-4, 5 0 -GGA-GCG-GGA-GAA-ATG-GA T-ATG-3 0 . Standard PCR conditions resulted in a 398-bp wild-type and a 320-bp mutant PCR product. The presence of Nes-, Camk2a-and Dlx-cre was evaluated using primers CRE-F, 5
0 -GAT-CGC-TGC-CAG-GAT-ATA-CG-3 0 and CRE-R 5 0 -AAT-CGC-CAT-CTT-CCA-GCA-G-3 0 resulting in a PCR product of 574 bp. Genotypes were confirmed by Southern blot analysis of EcoRV-digested tail DNA using the 5 0 -probe and a Cre-recombinase-specific probe. 23 The efficiency of Nes-cre-mediated excision of the transcriptional terminator sequence was demonstrated by Southern Conditional overexpression of CRH A Lu et al blot analysis of EcoRV-digested genomic DNA prepared from cortex, hippocampus, thalamus, cerebellum, tail and liver using the external 5 0 -probe. Mice used for this study were kept on a mixed 129S2/ Sv Â C57BL/6J background.
X-Gal staining
Animals (2-to 3-month old; n = 4-5 per genotype) were killed by an overdose of isoflurane and transcardially perfused with 4% paraformaldehyde, 2 mM MgSO 4 and 5 mM EGTA. Subsequent X-Gal staining was performed on free floating 50-or 100-mm thick vibratome sections or on intact organs as previously described. 22 In situ hybridization Mice (10-week old) were killed in the morning (10:00 am) by an overdose of isoflurane. For quantification of immediate early genes (IEGs) c-fos and zif268 animals were either killed under basal conditions or subjected to 10 min of forced swimming 30 min before killing. Brains were carefully removed and immediately shock-frozen on dry ice. Frozen brains were cut on a cryostat in 20-mm thick sections. For quantitative in situ hybridization cryostat sections of CRH-COE con and CRH-COE hom brains were mounted side by side on SuperFrost Plus slides (Menzel GmbH, Braunschweig, Germany). This procedure allowed for parallel in situ hybridization of sections under identical conditions assuring meaningful quantification and comparison of hybridization signals. All sections were processed for in situ hybridization according to a modified version of the procedure described by Dagerlind et al. 24 The following riboprobes were used: CRH, nucleotides 1306-1661 of GenBank accession no. AY128673; endogenous CRH (3 0 -UTR), nucleotides 1816-2107 of GenBank accession no. AY128673; CRH-R1, nucleotides 1570-2273 of GenBank accession no. NM_007762; c-fos, nucleotides 608-978 of GenBank accession no. NM_010234; zif268, nucleotides 245-786 of GenBank accession no. NM_007913 and LacZ, nucleotides 192-569 of GenBank accession no. U46489. Specific riboprobes were generated by PCR applying T7 and T3 or SP6 primers using plasmids containing above-mentioned cDNAs as templates. Antisense and sense cRNA probes were transcribed from 200 ng of respective PCR product and directly used as a template for the synthesis of radiolabeled transcripts by in-vitro transcription with 35 S-UTP (Amersham Biosciences, Piscataway, NJ, USA) using T7 and T3 RNA polymerase (Roche, Penzberg, Germany), respectively. After 20 min of DNase I (Roche) treatment, the probes were purified by the RNeasy Clean up protocol (Qiagen, Hilden, Germany) and measured in a scintillation counter. For hybridization, sections were pretreated and prehybridized as previously described. 24 Subsequently, they were hybridized overnight with a probe concentration of 7 Â 1 0 6 c.p.m. ml À1 at 57 1C and washed at 64 1C in 0.1 Â saline sodium citrate (SSC) and 0.1 mM dithiothreitol. The hybridized slides were dipped in autoradiographic emulsion (type NTB2; Eastman Kodak, Rochester, NY, USA), developed after 3-6 weeks and counterstained with cresyl violet.
For quantification, autoradiographs were digitized and relative levels of mRNA were determined by computer-assisted optical densitometry (ImageJ; http://rsb.info.nih.gov/ij/). For in situ hybridizations routinely three different exposure times were applied to assure that the signals to be quantified were in the linear range.
CRH radioimmunoassay
Mice (2-to 3-month old) were killed by cervical dislocation at 10:00 am. Brains were carefully removed and used in total or further dissected for selective preparation of cortex, hippocampus and thalamus. The CRH-specific radioimmunoassay (RIA) on tissue homogenates was performed after prior extraction as previously described. 25 
Endocrine analyses
Two weeks before the experiments, 3-to 5-month-old animals were separated and singly housed with a 12:12 h light:dark schedule (lights off at 07:00 pm). All experiments and data analyses were performed separately for male and female animals. To determine the basal hormone plasma levels, mice were left undisturbed throughout the night before the experiment. Blood sampling was performed in the early morning (07:30-09:30 am) and afternoon (04:30-05:30 pm) by collecting trunk blood from animals rapidly decapitated under light isoflurane anesthesia or by incision of the tail, with the time from first handling of the animal to completion of bleeding not exceeding 45 s. For evaluation of the endocrine response to stress, we collected blood samples immediately after and 30 min after 10-min restraint stress, for which animals were placed in a 50-ml conical tube with the bottom removed. Stress experiments were performed in the morning (07:30-10:00 am). Plasma corticosterone and ACTH concentrations were measured in duplicate by commercially available RIA kits (ICN Biomedicals, Irvine, CA, USA).
Subjects for behavioral testing
Mice were singly housed 2 weeks before experiments under standard laboratory conditions (22 ± 1 1C, 55±5% humidity) with food and water ad libitum under a 12:12 h inverted light:dark schedule (lights off at 09:00 am). Age of tested animals ranged between 3 and 6 months. Animal experiments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals of the Government of Bavaria. Experiments were performed during the dark, active phase of the animals between 01:00 pm and 06:00 pm hours under red light conditions, unless otherwise stated. Animals' behavior in the tail suspension and FST was analyzed online by trained observers who were blind to treatment and genotype. If not stated otherwise, male mice were used for the experiments. Experiments to assess the behavioral consequences of stress-regulated activation of endogenous CRH were performed on previously described CRH-R1 knockout mice, 26 which were kept on a mixed 129/Ola Â CD1 background. 
Open field
Forced swim test
Each mouse was placed in a 5-l glass beaker (height, 23.5 cm; diameter, 16.5 cm) containing 15 cm of water at 25 ± 1 1C or 32 ± 1 1C for 6 min. The water was changed between subjects. During each trial, floating (immobility) and struggling time was scored by pressing preset keys on a computer keyboard, using a customized freeware software (EVENTLOG). The resulting l-channel ethogram was further processed by customized software (Winrat version 2.31; Heinz Barthelmes, MPI Munich, Germany). A mouse was judged floating when it stopped any movements except those that were necessary to keep its head above water. Vigorous swimming movements involving all four limbs of the mouse with the front paws breaking the surface of the water, usually at the walls of the beaker, were regarded as struggling. The test was carried out on 2 consecutive days.
For the analysis of the influence of restraint stress experience on FST behavior, animals were subjected to 1 h of restraint stress in a 50-ml conical tube 4 h before exposure to forced swimming according to a previously established protocol for stress-induced activation of CRH-R1. 27 Tail suspension test Animals were suspended by the end of their tail with adhesive tape to a steel bar that was 35 cm above the floor. Each session lasted 6 min and was videotaped. The duration of immobility was scored by a trained observer who was blind to the animals' genotype, using EVENTLOG software. Mice were considered immobile only when they hung passively without moving the limbs or the head.
Pharmacology
All drugs were freshly prepared in a volume of 10 ml kg
À1
. DMP696 (Bristol-Myers Squibb, Munich, Germany) was suspended in a 0.9% saline solution containing 5% dimethyl sulfoxide, 5% polyethylene glycol 400 and 10 ml of Tween 80 per 1.5 ml (all chemicals from Sigma-Aldrich, Steinheim, Germany), and injected i.p. 1 h before the FST on days 1 and 2. For the analysis of DMP696 influences on stressinduced ACTH levels, mice were decapitated immediately after the FST on day 2.
Para-chlorophenylalanine methyl ester (PCPA) and a-methyl-para-tyrosine methyl ester (AMPT) (all drugs from Sigma-Aldrich, Steinheim, Germany) were suspended in a 0.9% saline solution containing 1% dimethyl sulfoxide and administered i.p. PCPA (250 mg per kg) was administered twice daily (every 12 h) for 3 days with the last dose given 18 h before the FST. 28 AMPT (200 mg per kg) was administered as a single dose 4 h before the FST. Determination of serotonin (5-hydroxytryptamine), 5-hydroxyindoleacetic acid, 3,4-dihydrophenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid was performed by reverse-phase high-performance liquid chromatography with electrochemical detection as previously described. 29 Hippocampal filtrates (20 ml stock solutions) were diluted and 50 ml were automatically injected by a CMA 200 refrigerated autosampler (CMA Microdialysis AB, Stockholm, Sweden). The mobile phase consisted of 93% phosphate buffer (0.1 M NaH 2 PO 4 , 1 mM sodium octanesulphonic acid, 10 mM NaCl and 0.5 mM Na 2 -EDTA) and 7% acetonitrile, and the pH was adjusted to 4.0 with o-phosphoric acid (all chemicals were from Merck, Darmstadt, Germany). For noradrenaline (NA) and dopamine (DA) tissue quantification, hippocampal filtrates (20 ml stock solutions) were diluted and concentration was determined by a radioenzymatic assay as previously described. This assay involves COMT-catalyzed O-methylation using [ 
Statistical analysis
Data were analyzed for multiple comparisons using one-, two-or three-way analyses of variance (ANOVAs) for repeated measures where appropriate, followed by post-hoc Newman-Keuls multiple comparison test. For two-group comparisons unpaired Student's t-test was used. Differences were considered statistically significant when P < 0.05. Data are presented as mean±s.e.m.
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Results
Generation of mutant mice conditionally overexpressing CRH in the CNS (CRH-COE-Nes)
We used homologous recombination in ES cells to target the ubiquitously expressed ROSA26 (R26) locus with a single copy of the murine Crh cDNA preceded by a loxP-flanked (floxed) transcriptional 'Stop' sequence (Figures 1a-c) . As previously reported, 20 mice homozygous for the modified R26 allele (R26 flopCrh/flopCrh floxed Stop), which is Cre-recombinase-sensitive, were indistinguishable from wild-type littermates, behaviorally (data not shown), as well as with respect to endogenous CRH mRNA (Figures 2e and f) and protein levels (Figure 3a) . Homozygous
R26
flopCrh/flopCrh mice were crossed to transgenic Nes-cre mice 17 allowing for a CNS-restricted overexpression of CRH in double transgenic animals (CRH-COE-Nes). In this mouse line Cre expression is controlled by the nestin promoter and neural enhancer, which drive cre expression in neuronal and glial precursors as early as embryonic day 10.5. 30 In the F 2 generation we obtained (Figures 2b, c, g and j) . The conditional overexpression of CRH was verified by in situ hybridization using a CRH-specific riboprobe. In CRH-COE con -Nes mice, endogenous CRH expression was detected heterogeneously throughout the entire CNS as previously described 31 ( Figures 2e and f) . In CRH-COE het -and CRH-COE hom -Nes mice, the pattern of CRH induction paralleled the activation of the IRES-LacZ reporter gene as demonstrated by X-Gal staining. Expression of exogenous CRH was detected at varying levels throughout the brain and attributed to the CNS-wide expression of Nes-cre and to the ubiquitous activity of the R26 locus. CRH mRNA was detected at highest levels in the olfactory bulb, cortex and hippocampus, again in a gene dosage-dependent manner (Figures 2h, i, k and l) . Moreover, we confirmed the increased CRH peptide content in the entire brain and various brain areas of CRH-COE hetNes and CRH-COE hom -Nes mice using a CRH-specific RIA (Figures 3a-e) . No difference in CRH peptide content was observed between CRH-COE wt -and CRH-COE con -Nes mice (Figure 3a) .
Expression of endogenous CRH and CRH-R1 is altered in the brain of CRH-COE-Nes mice
To explore alterations in the expression of endogenous CRH and CRH-R1 in response to exogenous CRH expressed from the R26 locus, we used in situ hybridization. We observed a strong decrease of endogenous CRH mRNA levels in the PVN (Supplementary Figure 1c) , in all areas of the hippocampus proper (CA1-CA3) and in the dentate gyrus (Supplementary Figure 1a ) of CRH-COE hom -Nes mice compared to control littermates. However, in the CeA (Supplementary Figure 1b) endogenous CRH mRNA levels were significantly increased. CRH-COE hom -Nes À1 tissue wet weight. *P < 0.05, **P < 0.01, ***P < 0.001.
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A Lu et al mice exhibited increased CRH-R1 mRNA levels in the hippocampus and dentate gyrus (Supplementary Figure 1d) . Surprisingly, CRH-R1 mRNA levels in the hippocampus were only increased in the CA2 and CA3, however not in CA1 (Supplementary Figure 1d) . In addition, CRH-R1 expression was significantly increased in the basolateral amygdala of homozygous CRH overexpressing mice (Supplementary Figure 1e) .
HPA axis of male but not female CRH-COE-Nes mice is hypersensitive to stress Basal plasma ACTH and corticosterone levels did not differ significantly between male CRH-COE con -, CRH-COE het -and CRH-COE hom -Nes mice over the circadian cycle, neither at the diurnal trough, nor at the diurnal peak (Supplementary Figures 2a and c) . To examine the response of the HPA axis to stress, animals were subjected to 10 min of restraint stress in the morning and killed either directly or 30 min after the end of the stressor ( Supplementary Figures 2b and d) . Restraint stress resulted in significantly elevated ACTH (F 2,32 = 7.5; P < 0.01) and corticosterone (F 2,32 = 4.10; P < 0.05) levels in male CRH-COE het -and CRH-COE Figures 2e and f) .
CNS-restricted overexpression of CRH results in decreased immobility in the FST and the tail suspension test
In the open field, CRH-COE hom mice showed no difference in locomotor activity compared to CRH-COE con littermates (Figure 4a ). CRH-COE hom mice did show increased exploratory behaviors compared to CRH-COE con littermates as indicated by an elevated number of vertical movements (rearings) (t 18 = 2.14, P < 0.05; Figure 4a ). To examine stress-coping behaviors, CRH-COE-Nes mice were exposed to the FST. In male mice, CRH overexpression resulted in a gene dosage-dependent decrease in floating in the FST both on day 1 (F 2,30 = 20.0; P < 0.001) and on day 2 (F 2,30 = 15.0; P < 0.001) with both CRH-COE hom -Nes and CRH-COE het -Nes mice floating significantly less than CRH-COE con -Nes littermates (Figure 4b ). Furthermore, CRH overexpression resulted in a dose-dependent increase in struggling both on day 1 (F 2,30 = 3.4; P < 0.05) and on day 2 (F 2,30 = 4.3; P < 0.05) with CRH-COE hom -Nes mice struggling generally more than CRH-COE Figure 3a) .
Exposure to cold water (25 1C) Figure 3b) .
To further corroborate the finding that CRH promotes a reduction of immobility in the FST, we subjected male animals to the tail suspension test (TST). 32 Again, CRH-COE hom -Nes mice displayed significantly decreased immobility compared to CRH-COE con -Nes and CRH-COE het -Nes littermates (F 2,83 = 8.9; P < 0.001), no difference was observed between CRH-COE het -Nes and CRH-COE con -Nes animals (Figure 4c ).
Effects of CRH overexpression on FST behavior can be reversed by the selective CRH-R1 antagonist DMP696
To ascertain that the behavioral as well as the neuroendocrine consequences of CRH overexpression rather relate to acute effects of CRH than to long-term changes in brain physiology caused by the life-long overexpression of CRH, we treated male CRH-COE het mice with the selective CRH-R1 antagonist DMP696. 33 Antagonist treatment dose-dependently reversed the FST phenotype by increasing floating time both on day 1 (F 2,35 = 4.4; P < 0.05; Figure 4d ) and on day 2 (F 2,35 = 4.4; P < 0.05; Figure 4d ). Furthermore, DMP696 attenuated the swim stress-induced hyperactivation of the HPA axis (F 2,14 = 10.6; P < 0.01; Figure 4e ).
Conditional CRH overexpression mimics the behavioral consequences of stress-induced activation of the endogenous CRH system
To assess whether overexpression of exogenous CRH mimics the behavioral consequences of stress-regulated activation of endogenous CRH, we analyzed FST behavior of CRH-R1 knockout (CRH-R1 À/À ) mice 26 and wild-type littermates (CRH-R1 þ / þ ) without or with prior 1-h restraint stress. In accordance with our previous findings, 34, 35 ablation of CRH-R1 failed to affect floating behavior in naive animals, thus arguing against a general involvement of endogenous CRH in FST behavior. However, prior restraint stress resulted in a decrease in floating in CRH-R1 þ / þ mice compared to nonstressed CRH-R1 þ / þ controls (t 27 = 3.7, P < 0.01) that was similar to the behavior of CRH-COE het -Nes and CRH-COE hom -Nes mice (Figure 4f ). The floating response was also significantly smaller than that of restraint stressed CRH-R1 À/À mice (t 29 = 3.1, P < 0.01), which remained unaffected by the stressor (t 27 = 1.2, P < 0.243). These results imply that the CRH system must be activated by prior stressor exposure before endogenous CRH may modulate behavior in the FST via CRH-R1.
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Forebrain-restricted overexpression of CRH in principal neurons or GABAergic interneurons does not affect stress-coping behavior in the FST In order to specify the brain regions and neurochemical substrates involved in the immobility-reducing effect of exogenous CRH, we exploited the properties of the conditional R26 flopCrh allele. Breeding CRH-COE con mice to Camk2a-cre 18 and Dlx-cre 19 mice restricted the CRH overexpression to principal neurons or GABAergic interneurons respectively, of the anterior forebrain including limbic brain structures. The Dlx5/6 promoter drives cre expression as early as embryonic day 10.5 (JL Rubenstein and M Ekker, unpublished data), whereas the Camk2a promoter het -Nes mice compared to vehicle-treated controls (0 mg per kg) both on day 1 (d1) and on day 2 (d2) (n = 12-13 animals per group). (e) DMP696 was able to attenuate the swim stress-induced increase of adrenocorticotropin (ACTH) on day 2 in CRH-COE het mice at doses of 10 and 50 mg per kg (n = 5-6 animals per group). (f) Previous exposure to restraint stress resulted in decreased floating behavior in the forced swim test in CRH type 1 receptor (CRH-R1) wild-type (CRH-R1 þ / þ ) mice compared to unstressed controls and stressed CRH-R1 knockout (CRH-R1
À/À ) animals on day 1. Restraint stress failed to significantly affect floating behavior of CRH-R1 À/À animals (n = 13-16 animals per group). *P < 0.05, **P < 0.01, ***P < 0.001.
Conditional overexpression of CRH
A Lu et al drives cre expression from around postnatal day 15.
18
Analogous to CRH-COE-Nes mice we obtained desired control (CRH-COE con -Cam/-Dlx), heterozygous (CRH-COE het -Cam/-Dlx) and homozygous (CRH-COE hom -Cam/-Dlx) CRH-COE-Cam/-Dlx mice, respectively in the F 2 generation. In situ hybridization confirmed the forebrain-restricted expression of exogenous CRH in both overexpressing mouse lines (Figures 5a,  c and e) . The function of the HPA axis of homozygous CRH-COE-Cam/-Dlx mice was not significantly altered compared to control mice, neither under basal nor under stress conditions (Supplementary  Figure 4) .
To examine whether forebrain-restricted expression of CRH is sufficient to recapitulate the immobilityreducing effect of exogenous CRH expressed throughout the CNS in CRH-COE-Nes mice, male CRH-COE hom -Cam and CRH-COE hom -Dlx mice were exposed to the FST. Forebrain-restricted CRH overexpression failed to significantly affect floating or struggling behavior (data not shown) in homozygous CRH-COE-Cam (Figure 5b ) or CRH-COE-Dlx (Figure 5d ) mice compared to control littermates, both on days 1 and 2.
Active stress-coping behavior of CRH overexpressing mice depends on catecholaminergic transmission CRH-COE-Cam as well as CRH-COE-Dlx mice suggest an involvement of more caudal brain nuclei within the mid/hind brain including monoaminergic cell populations overexpressing CRH, which promote the reduced immobility in the FST and TST. In an attempt to understand the neurochemical mechanisms underlying the behavior of CRH-COE-Nes mice in the FST, animals were pretreated with either the tryptophan hydroxylase inhibitor PCPA or the tyrosine hydroxylase inhibitor AMPT before testing in the FST. PCPA pretreatment reduced hippocampal serotonin levels by 85% in CRH-COE 
CRH overexpression enhances FST-mediated activation of the locus coeruleus
To determine to what extent CRH overexpression activates catecholaminergic neurons, we analyzed by in situ hybridization the transcript levels of IEGs c-fos and zif268 with focus on the locus coeruleus (LC), nucleus of the solitary tract, ventral tegmental area (VTA), substantia nigra (SN) and dorsal raphe nucleus (DRN). As previously demonstrated in the rat, expression of c-fos and zif268 in these nuclei was undetectable under basal conditions (data not shown). 36 However, 30 min post forced swim stress, a marked increase of c-fos and zif268 expression was detected in the LC (Figures 6c and e) but not in the VTA and SN or DRN (data not shown). Quantification of the signals revealed a stronger increase of c-fos (1.35-fold; t 6 = 4.24, P < 0.01) and zif268 (1.55-fold; t 6 = 6.15, P < 0.001) transcript levels in male CRH-COE hom -Nes mice than in CRH-COE con -Nes mice (Figures 6d and f) , suggesting an enhanced stress-dependent activation of the LC due to CRH overexpression.
To assess whether LC hyperactivation is independent of enhanced HPA axis reactivity, we also analyzed zif268 expression in female CRH-COE hom -Nes mice that do not show HPA axis hypersensitivity (compare Supplementary Figures 2e and f) . Similar to males, female CRH-COE hom -Nes mice showed a significantly stronger increase of zif268 expression (1.30-fold; t 10 = 3.12, P < 0.05) in the LC compared to CRH-COE con -Nes mice 30 min post forced swim stress (Figure 6g ).
Discussion
To genetically dissect the impact of excess CRH in distinct brain regions and neuronal cell populations on stress-coping behavior, we used a knock-in approach to generate a mouse model that allowed CRH overexpression at different levels in a spatially restricted manner. Superior to standard transgenesis this conditional mouse model provides the opportunity to generate and compare different CRH overexpressing mouse lines-as demonstrated by breeding to Nes-, Camk2a-and Dlx-cre mice-avoiding common uncertainties of transgene production such as copy number or site of transgene insertion. Although the pattern of CRH overexpression exclusively depends on the spatial and/or temporal properties of the introduced Cre recombinase, the transcriptional control via R26 guarantees for identical expression levels.
This approach enabled us to specifically investigate the CNS effects of different dosages of CRH in CRH-COE mice without affecting the peripheral CRH system or the circadian HPA axis regulation under basal conditions. Nevertheless, chronic overexpression of exogenous CRH activates compensatory mechanisms affecting the expression levels of endogenous CRH and CRH-R1 in a brain region-specific manner as demonstrated in CRH-COE-Nes mice. Alterations of endogenous CRH and CRH-R1 levels will mutually interfere with existing regulatory circuits and, in concert with effects of exogenous CRH expression, add another layer of complexity. For instance, expression of CRH in the PVN of CRH-COE hom -Nes is significantly decreased under basal conditions and thereby probably sensitizes or upregulates CRH-R1 in pituitary corticotrophs. As a consequence, basal ACTH and corticosterone plasma levels of male CRH-COE het -and CRH-COE hom -Nes mice are indistinguishable from those of control littermates, whereas the HPA axis of these animals is hyperreactive in response to stress. Interestingly, female CRH-COE hom -Nes mice displayed no such stress-dependent HPA axis hyperreactivity, supporting previous observations of gender differences in biological functions of the endogenous CRH system. 37 In CRH-COE hom -Nes mice we observed increased expression of CRH in the CeA as well as of CRH-R1 in the BLA and hippocampus. In contrast, Thy-1-driven overexpression in projection neurons of CRH-OE 2122 mice results in a rather uniform downregulation of CRH-R1 in several brain nuclei. 38 However, it is of notice that chronically increased corticosterone levels 15 might here dominate the effects on CRH-R1 expression compared to transgene CRH expression.
Male CRH-COE-Nes mice exhibited a marked gene dosage-dependent reduction of immobility in the FST and TST, which is not due to excessive stress hormone secretion, as female CRH-COE-Nes mice, which displayed normal HPA axis reactivity, showed similar behavioral alterations in the FST. Accordingly, neither CRH-R1 deletion 35 nor adrenalectomy resulted in altered forced swimming behavior. 39 In line with the observations in our chronic model of CRH excess, also the acute intracerebroventricular (i.c.v.) injection of CRH or cortagine, a potent CRH-R1 agonist, as well as site-directed injection of CRH into the LC, decreases immobility in the FST in rats and mice. [40] [41] [42] Furthermore, CRH-Tg mice also showed reduced immobility in the FST. 43 Interestingly, CRH has also been demonstrated to elicit antidepressantlike effects in a differential reinforcement of low-rate schedule in rats. 44 
Conditional overexpression of CRH
A Lu et al Quantification of zif268 mRNA expression in the locus coeruleus of female CRH-COE-Nes mice as determined by in situ hybridization. *P < 0.05, **P < 0.01, ***P < 0.001. The Porsolt FST is highly predictive for clinically effective antidepressants targeting the monoaminergic system, however, the construct of reduced immobility is not understood. 45 Immobility is thought to reflect either a failure of persistence in escape-directed behavior (that is, behavioral despair) or the development of passive behavior that disengages the animal from active forms of coping with stressful stimuli. 46 However, others have suggested that immobility could also reflect an adaptive mechanism to conserve energy. 47 Besides, the FST certainly also involves a strong component of arousal, alertness and stresscoping behavior. Therefore, decreased immobility in CRH-COE-Nes mice might rather reflect enhanced responsiveness to a stressful situation resulting in increased active coping behavior than antidepressantlike behavior. CRH has been demonstrated to influence neuronal connectivity in the developing hippocampus. 48 Hence, CRH overexpression starting from early embryogenesis might have caused adaptive changes of neuronal physiology. However, the attenuation of active coping behavior and of HPA axis hyperreactivity by pretreatment of CRH-COE het -Nes mice with the CRH-R1-selective antagonist DMP696 suggests that these phenotypes are an acute consequence of CRH overexpression. 33 Considering the observation that CRH-R1 antagonists exhibit highest efficacy in rodents that are hyperresponsive to stress and exhibit increased levels of CRH, 12, 39 CRH-COENes mice may constitute a mouse model with strong and predictable responsiveness to CRH-R1 antagonists.
To assure that the FST phenotype of CRH-COE-Nes mice is not of artificial nature, arising from excessive ectopic expression of CRH in the brain, we elucidated the role of the endogenous CRH system in FST behavior. Under basal, nonactivated conditions the endogenous CRH system does not influence FST behavior as neither the genetic disruption nor the pharmacological blockade of CRH-R1 affected FST behavior. 10, 34, 35 However, we could demonstrate that stress-mediated activation of the endogenous CRH system before the FST decreased immobility in control mice, but not in CRH-R1 knockout mice. These findings suggest that ectopic overexpression of CRH in CRH-COE-Nes mice mimics the behavioral consequences of stress-mediated activation of the endogenous CRH system, and that CRH-R1-dependent signaling pathways promote the increase in active coping behavior.
The forebrain-restricted disruption of CRH-R1 in CRH-R1 lox/lox Camk2a-cre mice decreases anxietyrelated behavior, 23 suggesting the involvement of CRH/CRH-R1-dependent pathways in structures of the anterior forebrain including those of the limbic system in emotionality control. In order to investigate whether these structures are also causally related to altered FST behavior, we spatially restricted CRH overexpression using Camk2a-cre mice. Similar to CRH-OE 2122 mice, 15 CRH overexpression in the forebrain did not result in the reduced immobility observed in CRH-COE-Nes (this study) and CRH-Tg mice, 14, 43 presumably owing to the overexpression in principal neurons only. To date the cellular and subcellular localization of CRH and its receptors including receptor-mediated effects at synapses are not well understood. In the hippocampus, endogenous CRH expression has been assigned to GABAergic interneurons from where CRH is released in the cause of acute physiological stress. 49 CRH release excites pyramidal cells, which express CRH-R1 postsynaptically on their dendritic spines. However, using Dlx-cre mice to direct CRH overexpression to GABAergic interneurons, in order to model more closely endogenous expression sites in the forebrain, failed to affect FST behavior. The absence of the FST phenotype in forebrain-specific CRH overexpressing mouse lines argues against volume transmission throughout the brain as mediating CRH effects, but clearly favors a mechanism involving specific synaptic release. Furthermore, our results suggest that CRH overexpression in more caudal brain nuclei of the mid/hind brain could promote the effects of CRH on stresscoping behavior.
In the brain stem of mice and rats CRH-R1 is expressed in serotonergic neurons of the median and DR 50 and in dopaminergic neurons of the SN and VTA. 51 CRH is expressed in noradrenergic neurons of the LC, 52 and i.c.v. injection of CRH has been demonstrated to induce a strong Fos immunoreactivity in the LC indicating the activation of CRH-Rdependent signaling pathways. 52 Accordingly, CRH is able to potentiate noradrenergic, 40 ,53 dopaminergic 54 and serotonergic 55 neurotransmission. Here we could demonstrate that the pharmacological blockade of catecholamine synthesis by AMPT, but not of serotonin synthesis by PCPA, could partially reverse the phenotype of CRH-COE hom -Nes mice. Therefore, it is likely that CRH overexpression activates the endogenous catecholaminergic system similarly as antidepressants, which would explain increased arousal in an open field and the reduced immobility in the FST and TST.
Quantification of c-fos and zif268 expression in response to forced swim stress further identifies the hyperactivation of noradrenergic neurons of the LC in CRH-COE-Nes mice. Intracoerulear microinfusion of CRH in rats has demonstrated that CRH can serve as an excitatory neurotransmitter in the LC 56 resulting in enhanced NA release in LC projection areas. 57 CRH-NA interactions not only occur in the LC, where CRH activates the LC, but also at the projections of the forebrain noradrenergic system, where NA stimulates CRH release. 58 For instance, stress induces NA release in the PVN and thereby stimulates secretion of CRH. 59 This feed-forward mechanism could be a causal factor to the hyperreactivity of the HPA axis upon stress.
In conclusion, we have created a new, highly flexible transgenic mouse model, which can help in dissecting the contribution of CRH-sensitive pathways involved in the transition from physiological to pathological stress responses, which are thought to underlie the etiology of affective and anxiety disorders. 6 This animal model is also suited for validating drug candidates targeting the central CRH system.
